Daily as of 3 Nov 16:00 ET
- Price
- above both $139.44 vs 50 $113.69 / 200 $78.40
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 10 Sep 2026 · projected 26 bars out · tested 3 bars
GRAL | GRAILNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$139.44
+$5.68 (+4.25%)
GRAIL (GRAL) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2026.
The 50 SMA has sat above the 200 on the daily since Sep 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits above the 50 and the 200 on the daily and the 4-hour.
Timeframe summary
Weekly
No weekly data
4-hour as of 3 Nov 16:00 ET
- Price
- above both $139.44 vs 50 $138.17 / 200 $91.25
- Projection
- No cross projected
- Test
- No active test
- Last cross
- No cross on record
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 10 Sep 2026 | 🟨Golden moderate | daily | 26 bars out | 3 bar cross test |
| 9 Apr 2026 | 💀Death steep | daily | 30 bars out | Not tested |
About GRAL
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$95M
4-hour coverageYes, since Oct 2025
History on recordSince 2026
SectorHealthcare
Cap bandmid